The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The history of clozapine and its emergence in the US market: a review and analysis
Abstract
Clozapine is known as the first `atypical' medication and is effective in people who have treatment-resistant schizophrenia. Its 1990 emergence in the USA was marked by considerable controversy over its high cost, due in large part to having been both the first new antipsychotic medication to come to market in over a decade and the need for comprehensive safety monitor ing within a decentralized health system. This paper traces the histor y of clozapine's discover y and development in Europe, its part in the 1975 Finnish agranulocytosis scare, and its subsequent volatile emergence in the USA. Analyses examine peripheral forces at the time, particularly the influence of political, corporate, medical and societal forces which shaped its market course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
The Social Transformation of American Medicine
Leavitt, J. W., & Starr, P. (1984) · The American Historical Review · doi:10.2307/1862729 · Cited by 3,247
A History of Psychiatry: From the Era of the Asylum to the Age of Prozac.
Herman, E., & Shorter, E. (1997) · The Journal of American History · doi:10.2307/2953108 · Cited by 1,056
Clozapine: A Novel Antipsychotic Agent
Oates, J. A., Wood, A. J. J., Baldessarini, R. J., & Frankenburg, F. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241107 · Cited by 687
Termination from Medi-Cal — Does It Affect Health?
Lurie, N., Ward, N. B., Shapiro, M. F., & Brook, R. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408163110735 · Cited by 302
Update on the Clinical Efficacy and Side Effects of Clozapine
Safferman, A., Lieberman, J. A., Kane, J. M., Szymanski, S., & Kinon, B. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.247 · Cited by 301
Povlsen, U. J., Norrng, U., Fog, R., & Gerlach, J. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01268.x · Cited by 278
CHLORPROMAZINE: New Inhibiting Agent for Psychomotor Excitement and Manic States
LEHMANN, H. E. (1954) · A.M.A. Archives of Neurology & Psychiatry · doi:10.1001/archneurpsyc.1954.02320380093011 · Cited by 251
Agranulocytosis during treatment with clozapine
Id�np��n-Heikkil�, J., Alhava, E., Olkinuora, M., & Palva, I. P. (1977) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606409 · Cited by 237
The Social Transformation of American Medicine
Schwartz, K. B. (1983) · The American Journal of Occupational Therapy · doi:10.5014/ajot.37.6.420a · Cited by 217
Clozapine-induced agranulocytosis: A genetic and epidemiologic study
de la Chapelle, A., Kari, C., Nurminen, M., & Hernberg, S. (1977) · Human Genetics · doi:10.1007/bf00393581 · Cited by 211
Gerlach, J., Koppelhus, P., Helweg, E., & Monrad, A. (1974) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1974.tb09706.x · Cited by 197
Idänpään-Heikkilä, J., Alhava, E., Olkinuora, M., & Palva, I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90206-8 · Cited by 181
Hippius, H. (1989) · Psychopharmacology · doi:10.1007/bf00442551 · Cited by 168
A historical perspective of clozapine.
Hippius, H. (1999) · PubMed · Cited by 166
The trial use of clozapine for abnormal involuntary movement disorders
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.3.317 · Cited by 161
Agranulocytosis in patients treated with clozapine
Amsler, H. A., Teerenhovi, L., Barth, E., Harjula, K., & Vuopio, P. (1977) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1977.tb00224.x · Cited by 155
Kritische Stellungnahme zum Begriff der Neuroleptika
Stille, G., & Hippius, H. (1971) · Pharmacopsychiatry · doi:10.1055/s-0028-1094311 · Cited by 124
Clozapine--a new antipsychotic agent.
Simpson, G. M., & Varga, E. (1974) · PubMed · Cited by 120
A history of psychiatry: from the era of the asylum to the age of prozac
(1997) · Choice Reviews Online · doi:10.5860/choice.34-6554 · Cited by 120
Miller, C. A. (1985) · Scientific American · doi:10.1038/scientificamerican0785-31 · Cited by 94
Griffith, R., & Saameli, K. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90135-x · Cited by 89
Clozapine-induced agranulocytosis: A situation report up to August 1976
Anderman, B., & Griffith, R. (1977) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606410 · Cited by 86
A review of clozapine: An antipsychotic for treatment-resistant schizophrenia
Stephens, P. (1990) · Comprehensive Psychiatry · doi:10.1016/0010-440x(90)90038-t · Cited by 49
Health Access America—Strengthening the US Health Care System
Todd, J. S., Seekins, S. V., Krichbaum, J. A., et al. (1991) · JAMA · doi:10.1001/jama.1991.03460190079024 · Cited by 40
The current status of clozapine.
Shopsin, B., & Feiner, N. F. (1983) · PubMed · Cited by 16
Cited by
Current Concepts and Treatments of Schizophrenia
Stępnicki, P., Kondej, M., & Kaczor, A. A. (2018) · Molecules · doi:10.3390/molecules23082087 · Cited by 556
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Clozapine versus typical neuroleptic medication for schizophrenia
Essali, A., Al-Haj Haasan, N., Li, C., & Rathbone, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000059.pub2 · Cited by 329
International trends in clozapine use: a study in 17 countries
Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12742 · Cited by 314
What Do We Know About Neuropsychological Aspects Of Schizophrenia?
Palmer, B. W., Dawes, S. E., & Heaton, R. K. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9109-y · Cited by 316
Metadata
- Authors
- Crilly, J.
- Venue
- History of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2007-03
- Volume
- 18
- Issue
- 1
- Pages
- 39-60
- ISSN
- 0957-154X (ISSN-L)
- 1740-2360
- OpenAlex
- W1995063674
- Cited by
- 272
- References
- 28
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.